2GODFREY KR, ARUNDEL PA, DONG Z, et 01. Modelling the double peak phenomenon in pharmacokinetics[J]. Comput Methods Programs Biomed, 2011, 14(2): 62-69.
3OKUSANYA O, FORREST A, DIFRANCESCO R, et ol. Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks[J]. Antimicrob Agents C hemother, 2007, 51 (5): 1822-1826.
4MACHERAS P, ARGYRAKIS P. Gastrointestinal drug ab- sorption: is it time to consider heterogeneity as well as homogeneity?[J]. Pharma Res, 1997, 14(7) : 842-847.
5ZHOU H. Pharmacokinetic strategies in deciphering atypical drug absorption profiles[J]. J Clin Pharmacol, 2003, 43 (3): 211-227.
6OBERLE RL, AMIDON GL. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve ofcimetidine; an explanation for the double peak phenomenon[J]. J Pharmacokinet Biooharm, 1987, 15(5) : 529-544.
7MARATHE PH, SANDEFER EP, KOLLIA GE, et al. In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma seintigraphy [J]. J Phal-nacokinet Biopharm, 1998, 26(1): 1-20.
8GRUNDY JS, ELIOT LA, KULMATYCKI KM, et ol. Grapefruit juice and orange juice effects on the bioavailability of nifedipine in the rat[J]. Biopharm Drug Dispos, 1998, 19(3): 175-183.
9SANAKA M, YAMAMOTO T, TSUTSUMI H, et al. Wagner- Nelson method for analysing the atypical double-peaked [-3CO2] exeretion curve in the [-3C]-octanoate gastric emptying breath test in humans[J]. Clin Exp Pharmacol Physiol, 2005, 32(7) : 590- 594.
10CHANG RK, SHOJAE1 AH. Effeet of a lipoidic excipient on the absorption profile of compound UK81252 in dogs after oral administration[J]. J Pharm Pharm Sci, 2004, 7(1): 8-12.
